Publication:
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Suggested Citation

Tauangtham Anekpuritanang, Matthew M. Klairmont, Joel Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil Chandra, Yiwei Liu, Heather L. Mulder, John Easton, Jinghui Zhang, Michael G. Martin, Anna B. Owczarczyk, Jennifer B. Dunlap, Guang Fan, Richard D. Press, Philipp W. Raess In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported. Blood Advances. Vol.5, (2021), 5057-5059. doi:10.1182/bloodadvances.2021004983 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77401